Targeting tumor-specific inflammatory process may prevent drug resistance in colon cancer Post author:admin Post published:May 21, 2026 Post category:uncategorized Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. You Might Also Like Study reveals novel therapeutic approach for excessive alcohol use June 25, 2024 Study challenges link between proton pump inhibitors and kidney disease risk December 5, 2023 Engineered enzyme enables fast and accurate RNA synthesis February 9, 2026